课题基金 / 基金详情

THE EFFECTS OF PENTOXIFYLLINE ON PAI-1 IN OBESE POPULATION

THE EFFECTS OF PENTOXIFYLLINE ON PAI-1 IN OBESE POPULATION
己酮可可碱对肥胖人群中 PAI-1 的影响
批准号：
7731493
负责人：
Douglas E Vaughan
金额：
$0.02万
依托单位：
VANDERBILT UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-09-16
来源：
https://reporter.nih.gov/project-details/7731493
关键词：
BloodComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionObesityPentoxifyllinePlasminogen Activator Inhibitor 1ResearchResearch PersonnelResourcesSourceUnited States National Institutes of Health

项目摘要

项目成果

Douglas E Vaughan的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Pentoxifylline will reduce levels of circulating PAI-1 in the blood
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evolutionary Advantage of Heterozygous PAI-1 Deficiency in Humans
Spontaneous cardiac fibrosis in PAI-1-deficient mice and men: A rare mutation informs a common molecular pathophysiology
Spontaneous cardiac fibrosis in PAI-1-deficient mice and men: A rare mutation informs a common molecular pathophysiology
Cardiovascular Regenerative Medicine